Literature DB >> 22233891

Knock-down of postsynaptic density protein 95 expression by antisense oligonucleotides protects against apoptosis-like cell death induced by oxygen-glucose deprivation in vitro.

Jing-Zhi Yan1, Yong Liu, Yan-Yan Zong, Guang-Yi Zhang.   

Abstract

OBJECTIVE: Postsynaptic density protein 95 (PSD-95) plays important roles in the regulation of glutamate signaling, such as that of N-methyl-D-aspartate receptors (NMDARs). In this study, the functional roles of PSD-95 in tyrosine phosphorylation of NMDAR subunit 2A (NR2A) and in apoptosis-like cell death induced by oxygen-glucose deprivation (OGD) in cultured rat cortical neurons were investigated.
METHODS: We used immunoprecipitation and immunoblotting to detect PSD-95 protein level, tyrosine phosphorylation level of NR2A, and the interaction between PSD-95 and NR2A or Src. Apoptosis-like cells were observed by 4,6-diamidino-2-phenylindole staining.
RESULTS: Tyrosine phosphorylation of NR2A and apoptosis-like cell death were increased after recovery following 60-min OGD. The increases were attenuated by pretreatment with antisense oligonucleotides against PSD-95 before OGD, but not by missense oligonucleotides or vehicle. PSD-95 antisense oligonucleotides also inhibited the increased interaction between PSD-95 and NR2A or Src, while NR2A expression did not change under this condition.
CONCLUSION: PSD-95 may be involved in regulating NR2A tyrosine phosphorylation by Src kinase. Inhibition of PSD-95 expression can be neuroprotective against apoptosis-like cell death after recovery from OGD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22233891      PMCID: PMC5560291          DOI: 10.1007/s12264-012-1065-5

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  28 in total

Review 1.  NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity.

Authors:  D W Ali; M W Salter
Journal:  Curr Opin Neurobiol       Date:  2001-06       Impact factor: 6.627

2.  Interactions between Src family protein tyrosine kinases and PSD-95.

Authors:  Lorraine V Kalia; Michael W Salter
Journal:  Neuropharmacology       Date:  2003-11       Impact factor: 5.250

3.  Subunit counting in membrane-bound proteins.

Authors:  Maximilian H Ulbrich; Ehud Y Isacoff
Journal:  Nat Methods       Date:  2007-03-18       Impact factor: 28.547

4.  Rules of engagement for NMDA receptor subunits.

Authors:  Maximilian H Ulbrich; Ehud Y Isacoff
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-08       Impact factor: 11.205

5.  PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A.

Authors:  T Tezuka; H Umemori; T Akiyama; S Nakanishi; T Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

Review 6.  Interaction of ion channels and receptors with PDZ domain proteins.

Authors:  H C Kornau; P H Seeburg; M B Kennedy
Journal:  Curr Opin Neurobiol       Date:  1997-06       Impact factor: 6.627

7.  Activation of NMDA receptors and L-type voltage-gated calcium channels mediates enhanced formation of Fyn-PSD95-NR2A complex after transient brain ischemia.

Authors:  Xiao-Yu Hou; Guang-Yi Zhang; Jing-Zhi Yan; Min Chen; Yong Liu
Journal:  Brain Res       Date:  2002-11-15       Impact factor: 3.252

8.  Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein.

Authors:  R Sattler; Z Xiong; W Y Lu; M Hafner; J F MacDonald; M Tymianski
Journal:  Science       Date:  1999-06-11       Impact factor: 47.728

9.  Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95.

Authors:  Li Zhou; Fei Li; Hai-Bing Xu; Chun-Xia Luo; Hai-Yin Wu; Ming-Mei Zhu; Wei Lu; Xing Ji; Qi-Gang Zhou; Dong-Ya Zhu
Journal:  Nat Med       Date:  2010-11-21       Impact factor: 53.440

10.  The postsynaptic NMDA-receptor--PSD-95 signaling complex in excitatory synapses of the brain.

Authors:  M Sheng
Journal:  J Cell Sci       Date:  2001-04       Impact factor: 5.285

View more
  1 in total

Review 1.  The Development of Novel Drug Treatments for Stroke Patients: A Review.

Authors:  Dmitry Frank; Alexander Zlotnik; Matthew Boyko; Benjamin Fredrick Gruenbaum
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.